High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results. 1981

N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson

This communication provides a description and update of the three adjuvant regimens utilized at the Sidney Farber Cancer Institute. The disease-free survivals are: Study I--42% at 4 years; Study II--58% at 3 years; and Study III--currently 78%. In the limb salvage experience, among the evaluable patients, 6 of 12 treated with preoperative chemotherapy are disease free (median 32 months) and 12 of 14 (86%) treated without preoperative chemotherapy are disease free (median 13 months).

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000671 Amputation, Surgical The surgical removal of part of, or all of, a limb or other appendage or outgrowth of the body. Amputation,Amputation, Multiple, Surgical,Multiple Amputation, Surgical,Surgical Amputation Procedures,Amputation Procedure, Surgical,Amputation Procedures, Surgical,Amputation, Surgical Multiple,Amputations,Amputations, Surgical,Amputations, Surgical Multiple,Multiple Amputations, Surgical,Procedure, Surgical Amputation,Procedures, Surgical Amputation,Surgical Amputation,Surgical Amputation Procedure,Surgical Amputations,Surgical Multiple Amputation,Surgical Multiple Amputations
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies

Related Publications

N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
April 1981, National Cancer Institute monograph,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
May 1988, Zhonghua zhong liu za zhi [Chinese journal of oncology],
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
January 1990, Voprosy onkologii,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
May 1979, Cancer treatment reports,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
October 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
November 1983, Alabama medicine : journal of the Medical Association of the State of Alabama,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
January 1994, Cancer chemotherapy and pharmacology,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
June 1978, Blut,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
February 1978, Cancer treatment reports,
N Jaffe, and A Goorin, and M Link, and H Watts, and E Frei, and G Vawter, and K E Fellows, and G P Beardsley, and H T Abelson
February 1988, European journal of cancer & clinical oncology,
Copied contents to your clipboard!